Aerogen and IARC Ink strategic MoU to transform respiratory care

Aerogen, a leading global company in acute-care aerosol drug delivery based in Ireland, partnered with the Indian Association of Respiratory Care (IARC) to advance respiratory therapy education and enhance patient care throughout India. This strategic partnership signifies a significant milestone in the advancement of respiratory care and underscores a mutual dedication to enhancing respiratory services and results for patients across the country.

The IARC, which includes more than 500 respiratory therapists, offers educational resources and updates on critical care in India and overseas. IARC provides support for respiratory care in hospitals, home care, and training programs with a strong advisory board of top medical experts. Aerogen, in contrast, focuses on researching and developing to enhance its range of products and establish higher standards for quality and efficiency in aerosol drug delivery technology.

This collaboration merges Aerogen's knowledge with IARC's connections, centering on educational efforts to enhance the skills of respiratory therapists in India for the changing demands of critical care.

Debabrata Bhowmick, commercial director, Aerogen India, emphasized, "This partnership is pivotal in fostering innovation in respiratory care education and enhancing patient outcomes in India. By merging Aerogen's technology with IARC’s expertise, we are setting new standards in care while empowering healthcare professionals with the tools and knowledge to excel." The collaboration will utilize Aerogen's innovative medication administration technologies to enhance patient care in critical environments, enhancing outcomes and respiratory services in healthcare facilities throughout India.